Temasek Holdings (incorporated in 1974) is a global investment firm concentrated principally in Singapore, Asia, and the OECD economies. Temasek's investment strategies center on four themes - Transforming Economies, Thriving Middle Class, Deepening ...Show all
Phone: +65 6828 6828
60B Orchard Road, #06-18 Tower 2
The Atrium at Orchard
238891
Singapore
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-05-21 | Iora Health | Series E | $100M | .406 Ventures, Devonshire Investors, F-Prime Capital, Flare Capital Partners, GE Ventures, Humana Ventures, Khosla Ventures, and Polaris Partners |
| 2018-05-15 | MediSix Therapeutics | Series A | $20M | Lightstone Ventures, and Osage University Partners |
| 2018-05-09 | Akili Interactive Labs | Series C | $55M | Amgen Ventures, Baillie Gifford & Co., Brooklands Capital Strategies, Canepa Advanced Healthcare Fund, Jazz Venture Partners, and Merck Ventures |
| 2018-04-26 | Innovent Biologics | Series E | $150M | Ally Bridge Group, Capital Group Private Markets, Cormorant Asset Management, Hillhouse Capital Management, Legend Capital, Lilly Asia Ventures, Rock Springs Capital, and Taikang Life Insurance Company |
| 2018-04-16 | Bayer | PIPE | $3.7B |
